Open Access
Volume 7, Number 2, June 2017
Article Number 9
Number of page(s) 6
Published online 14 June 2017
  1. Poirel L, Naas T, Nordmann P. Genetic support of extended- spectrum beta-lactamases. Clin Microbiol Infect. 2008; 14 Suppl 1: 75–81. [CrossRef] [PubMed] [Google Scholar]
  2. Hall RM, Collis CM. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol. 1995; 15: 593–600. [CrossRef] [PubMed] [Google Scholar]
  3. Baquero F.. Environmental stress and evolvability in microbial systems. Clin Microbiol Infect. 2009; 15 Suppl 1: 5–10. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Luzzaro F, Perilli M, Amicosante G, Lombardi G, Belloni R, Zollo A, et al. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Int J Antimicrob Agents. 2001; 17: 131–135. [CrossRef] [PubMed] [Google Scholar]
  5. Adler A, Baraniak A, Izdebski R, Fiett J, Gniadkowski M, Hryniewicz W, et al. A binational cohort study of intestinal colonization with extended-spectrum beta-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres. Clin Microbiol Infect. 2013; 19: E51–E58. [CrossRef] [PubMed] [Google Scholar]
  6. Wang JT, Chen PC, Chang SC, Shiau YR, Wang HY, Lai JF, et al. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. BMC Infect Dis. 2014; 14: 486. [CrossRef] [PubMed] [Google Scholar]
  7. Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, et al. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum beta-lactamases in China. Int J Antimicrob Agents. 2015; 45: 485–490. [CrossRef] [PubMed] [Google Scholar]
  8. Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis. J Clin Microbiol. 2008; 46: 30803083. [CrossRef] [Google Scholar]
  9. Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Pournaras S, Markou F. Transmission in the community of clonal Proteus mirabi- lis carrying VIM-1 metallo-beta-lactamase. J Antimicrob Chemother. 2007; 60: 136–139. [CrossRef] [PubMed] [Google Scholar]
  10. Luzzaro F, Brigante G, D’Andrea MM, Pini B, Giani T, Mantengoli E, et al. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Int J Antimicrob Agents. 2009; 33: 328–333. [CrossRef] [PubMed] [Google Scholar]
  11. Wu LT, Wu HJ, Chung JG, Chuang YC, Cheng KC, Yu WL. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan. Diagn Microbiol Infect Dis. 2006; 54: 89–94. [CrossRef] [Google Scholar]
  12. Fluit AC, Schmitz FJ. Resistance integrons and super-integrons. Clin Microbiol Infect. 2004; 10: 272–288. [CrossRef] [PubMed] [Google Scholar]
  13. Mazel D. Integrons: agents of bacterial evolution. Nat Rev Microbiol. 2006; 4: 608–620. [CrossRef] [PubMed] [Google Scholar]
  14. Partridge SR, Tsafnat G, Coiera E, Iredell JR. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol Rev. 2009; 33: 757–784. [CrossRef] [PubMed] [Google Scholar]
  15. Domingues S, da Silva GJ, Nielsen KM. Global dissemination patterns of common gene cassette arrays in class 1 integrons. Microbiology. 2015; 161: 1313–1337. [CrossRef] [PubMed] [Google Scholar]
  16. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol. 2000; 38: 542–546. [PubMed] [Google Scholar]
  17. Clinical and Laboratory Standards Institute (CLSI. Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement M100-S15., Wayne, PA: Clinical and Laboratory Standards Institute., 2005. [Google Scholar]
  18. Iyobe S, Kusadokoro H, Ozaki J, Matsumura N, Minami S, Haruta S, et al. Amino acid substitutions in a variant of IMP-1 metallo-beta- lactamase. Antimicrob Agents Chemother. 2000; 44: 2023–2027. [CrossRef] [PubMed] [Google Scholar]
  19. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991; 19: 6823–6831. [CrossRef] [PubMed] [Google Scholar]
  20. Huang CW, Chien JH, Peng RY, Tsai DJ, Li MH, Lee HM, et al. Molecular epidemiology of CTX-M-type extended-spectrum beta-lactamase-producing Proteus mirabilis isolates in Taiwan. Int J Antimicrob Agents. 2015; 45: 84–85. [CrossRef] [PubMed] [Google Scholar]
  21. Sheng WH, Badal RE, Hsueh PR, Program S. Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intraabdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother. 2013; 57: 2981–2988. [CrossRef] [PubMed] [Google Scholar]
  22. Gestal AM, Stokes HW, Partridge SR, Hall RM. Recombination between the dfrA12-orfF-aadA2 cassette array and an aadA1 gene cassette creates a hybrid cassette, aadA8b. Antimicrob Agents Chemother. 2005; 49: 4771–4774. [CrossRef] [PubMed] [Google Scholar]
  23. Chang LL, Chang TM, Chang CY. Variable gene cassette patterns of class 1 integron-associated drug-resistant Escherichia coli in Taiwan. Kaohsiung J Med Sci. 2007; 23: 273–280. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  24. Kang HY, Jeong YS, Oh JY, Tae SH, Choi CH, Moon DC, et al. Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J Antimicrob Chemother. 2005; 55: 639–644. [CrossRef] [PubMed] [Google Scholar]
  25. Lee MF, Chen YH, Peng CF. Molecular characterisation of class 1 integrons in Salmonella enterica serovar Choleraesuis isolates from southern Taiwan. Int J Antimicrob Agents. 2009; 33: 216–222. [CrossRef] [PubMed] [Google Scholar]